Company: AFRM
Filing Date: 2025-10-24
Form Type: DEF 14A
Source: 0001628280-25-046264
Chunk: 61

Company: Affirm Holdings, Inc.
Filing Date: 2025-10-24
Form: DEF 14A
Chunk 61
---
TABLE OF CONTENTS

### CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS
We describe below transactions and series of similar transactions, since the beginning of our last fiscal year, to which we were a party or will be a party, in which :

• the amounts involved exceeded or will exceed $120,000; and

• any of our directors, executive officers or holders of more than 5% of our common stock, or any member of the immediate family of, or person sharing the household with, the foregoing persons (each, a “related person”), had or will have a direct or indirect material interest.

We believe the terms of the transactions described below were comparable to terms we could have obtained in arm’s-length dealings with unrelated third parties.

#### Transactions
On May 31, 2023, we entered into an origination program agreement with Lead Bank, an FDIC-insured Missouri state-chartered bank. Jacqueline D. Reses, a member of our Board, is the Chief Executive Officer of Lead Bank. During the fiscal year ended June 30, 2025, Lead Bank originated $5.4 billion of loans through our platform, and we paid an aggregate amount of direct fees plus interest on originated loans received by Lead Bank during fiscal 2025 of approximately $4.6 million.

As described under “ Security Ownership of Certain Beneficial Owners and Management ,” as of September 30, 2025, Morgan Stanley & Co. LLC (“Morgan Stanley”), through its wholly owned subsidiary, Morgan Stanley Investment Management Inc. ("MSIM"), held 22,115,546 shares of our Class A common stock, representing 7.66% of the outstanding Class A shares. In December 2024, Morgan Stanley assisted in facilitating transactions relating to the issuance of the Company’s 0.75% convertible senior notes due 2029 (the “2029 Notes”), the repurchase of the Company’s 0% convertible notes due 2026 (the “2026 Notes”), and the repurchase of shares of the Company’s Class A common stock. Additionally, on May 15, 2025, we entered into a 10b5-1 Purchase Agreement with Morgan Stanley relating to the privately negotiated repurchases of up to $200 million aggregate principal amount of our 2026 Notes. As of June 30, 2025, these transactions resulted in approximately $6.4 million in aggregate fees to Morgan Stanley & Co. LLC.

On March 21,